Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07449520

Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)

Sponsor: IHU Strasbourg

View on ClinicalTrials.gov

Summary

EGO-Trial is the first multicenter study in France which aims to evaluate the efficacy of Endoscopic Sleeve Gastroplasty (ESG) in patients with obesity. This project fills a critical national gap by providing real-world, multicentric data from diverse French healthcare settings, offering insight into the safety, efficacy, and variability of ESG practices across institutions The project is expected to generate robust, multicentric clinical evidence on the safety and efficacy of ESG in patients with obesity within the French healthcare context.

Official title: Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

OBSERVATIONAL

Enrollment

300

Start Date

2026-03

Completion Date

2030-03

Last Updated

2026-03-04

Healthy Volunteers

No

Conditions

Interventions

PROCEDURE

Endoscopic sleeve gastroplasty

Endoscopic sleeve gastroplasty is performed using a CE marked endoscopic suture device which allows for a reduction in stomach volume without resection or anastomosis

Locations (10)

Hôpital Privé de Provence

Aix-en-Provence, France

Polyclinique de Franche-Comté

Besançon, France

Clnique des Cèdres

Échirolles, France

Hôpital HURIEZ

Lille, France

Hospices Civils de Lyon - Hôpital Edourard HERRIOT

Lyon, France

Clinique Clémentville

Montpellier, France

Centre Mutualiste de l'Obésité

Saint-Etienne, France

Polyclinique Sainte Thérèse

Sète, France

Hôpitaux Universitaires de Strasbourg, Nouvel Hôpital Civil

Strasbourg, France

Clinique les Eaux Claires

Baie-Mahault, Guadeloupe